US Patent 10077259 Bicyclic heterocyclic derivatives as bromodomain inhibitors
Patent 10077259 was granted and assigned to Orion Corporation on September, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10077259 Bicyclic heterocyclic derivatives as bromodomain inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
